10.1 TYPES OF ANALYTICAL PROCEDURES TO BE VALIDATED
- Identification tests
- Quantitative tests for impurities' content
- Limit tests for control of impurities
- Quantitative tests of the active ingredient in the sample (assay and dissolution)
- Pyrogen or Bacterial endotoxin test
- Sterility test
- Microbial Contamination Test
- Biological Assay of Antibiotics
10.2 TYPICAL VALIDATION PARAMETERS FOR CHEMICAL TESTS
10.2.1 FULL VALIDATION FOR IN-HOUSE METHODS
TABLE IX:
Characteristics |
Type of Analytical Method |
|||
Identification |
Testing for Impurities |
Assay:
|
||
Quantitation |
Limit |
|||
Accuracy |
|
√ |
|
√ |
Precision Repeatability |
|
√ |
|
√ |
Specificity (2) |
√ |
√ |
√ |
√ |
Detection Limit |
|
(3) |
√ |
|
Quantitation Limit |
|
√ |
|
|
Linearity |
|
√ |
|
√ |
Range |
|
√ |
|
√ |
10.2.2 PARTIAL VALIDATION FOR COMPENDIAL/PHARMACOPOEIAL METHODS
TABLE X:
Characteristics
|
Type of Analytical Method |
|||
Identification |
Testing for Impurities |
Assay:
|
||
Quantitation |
Limit |
|||
Precision |
|
√ (1) |
|
√ (1) |
Specificity (2) |
√ |
√ |
√ |
√ |
Detection Limit |
|
(3) |
√ |
|
Quantitation Limit |
|
√ |
|
|
Note:
√ signifies that this characteristic is normally evaluated.
(1) In cases where reproducibility has been performed, intermediate precision is not needed.
(2) Lack of specificity of one analytical procedure could be compensated by other supporting analytical procedure(s).
(3) May be needed in some cases.
10.3 TYPICAL VALIDATION CHARACTERISTICS FOR MICROBIOLOGICAL TESTS:
Table XI:
Microbiological tests |
Validation characteristics |
Bacterial Endotoxin Test |
|
Sterility Test |
Validation (Bacteriostasis or Fungistasis) Test
|
Microbial Contamination Test |
|
Microbiological Assay of Antibiotics |
Linearity of the dose response relationship |
Note:
- All the analytical validation done by the industry should be in accordance to ASEAN Guidelines for Analytical Procedures, ICH Technical Requirements for Registration of Pharmaceuticals for Human Use under Validation of Analytical Procedures: Text and Methodology Q2 (R1), British Pharmacopoeia (BP), United States Pharmacopoeia (USP), or Japanese Pharmacopoeia (JP).
- The applicants should ensure all documents available in the online Quest system are of the latest versions. All correspondence on the protocol of analysis and analytical method validation should comply with any relevant circulars regarding the registration process. Failure to do so may cause cancellation or rejection of product registration.